Titolo	Data di pubblicazione	Autore(i)
1	Zoledronic acid targets tumor-associated macrophages to overcome the resistance to the anti-angiogenic therapy in a mouse model of spontaneous cervical cancer	2012	S. Capano; F. Bussolino; E. Giraudo
2	Why is plasma infusion useful in hemolytic uremic syndrome?	1984	STRATTA P; CANAVESE C; F. BUSSOLINO; VERCELLONE A
3	VRG: A database of vascular dysfunctions related genes	2008	S. ZANIVAN; D. CORA'; M. CASELLE; F. BUSSOLINO
4	VEGF blockade enhances the antitumor effect of BRAFV600E inhibition	2017	Comunanza, Valentina; Cora', Davide; Orso, Francesca; Consonni, Francesca Maria; Middonti, Emanuele; DI NICOLANTONIO, Federica; Buzdin, Anton; Sica, Antonio; Medico, Enzo; Sangiolo, Dario; Taverna, Daniela; Bussolino, Federico
5	Vasculogenic potential of long term repopulating cord blood progenitors	2004	DROETTO S; VIALE A; PRIMO L; JORDANEY N; BRUNO S; PAGANO M; PIACIBELLO W; BUSSOLINO F; AGLIETTA M
6	Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells.	1999	MARCHIÒ S; PRIMO L; PAGANO M; PALESTRO G; ALBINI A; VEIKKOLA T; CASCONE I; ALITALO K; BUSSOLINO F
7	Unraveling the influence of endothelial cell density on VEGF-A signaling	2012	Napione, L; Pavan, S; Veglio, A; Picco, A; Boffetta, G; Celani, A; Seano, G; Primo, L; Bussolino, F
8	Type I collagen limits VEGFR-2 signaling by a SHP2 protein-tyrosine phosphatase-dependent mechanism 1	2006	MITOLA S; BRENCHIO B; PICCININI M; TERTOOLEN L; ZAMMATARO L; BREIER G; RINAUDO MT; DEN HERTOG J; ARESE M; BUSSOLINO F
9	Tumor-host interaction mediates the regression of BK virus-induced vascular tumors in mice: involvement of transforming growth factor-beta1.	2003	CORALLINI A; POSSATI L; TRABANELLI C; GIRAUDO E; ROCCHETTI R; TALEVI S; CAPUTO A; BUSSOLINO F; BARBANTI-BRODANO G
10	Tumor progression: the neuronal input	2018	Arese, Marco; Bussolino, Federico; Pergolizzi, Margherita; Bizzozero, Laura; Pascal, Davide
11	Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor.	1987	CAMUSSI G ;BUSSOLINO F ;SALVIDIO G ;BAGLIONI C
12	Tumor necrosis factor-alpha in airway secretions from cystic fibrosis patients upregulate endothelial adhesion molecules and induce airway epithelial cell apoptosis: implications for cystic fibrosis lung disease	2008	Mitola S; Sorbello V; Ponte E; Copreni E; Mascia C; Bardessono M; Goia M; Biasi F; Conese M; Poli G; Bussolino F; De Rose V.
13	Tumor necrosis factor-a regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells.	1998	E. GIRAUDO; L. PRIMO; E. AUDERO; H.P. GERBER; F. BUSSOLINO
14	Tumor necrosis factor stimulates human neutrophils to release leukotriene B4 and platelet-activating factor. Induction of phospholipase A2 and cetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine O2-acetyltransferase activity and inhibition by antiproteinase.	1989	G. Camussi; Tetta C; F. Bussolino; Baglioni C.
15	Tumor necrosis factor induces contraction of mesangial cells and alters their cytoskeletons.	1990	G. Camussi; Turello E; Tetta C; F. Bussolino; Baglioni C.
16	Tumor necrosis factor alters cytoskeletal organization and barrier function of endothelial cells.	1991	CAMUSSI G ;TURELLO E ;BUSSOLINO F ;BAGLIONI C
17	Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis.	1994	Montrucchio G; Lupia E; Battaglia E; Passerini G; F. Bussolino; Emanuelli G; G. Camussi
18	Tumor angiogenesis	1999	F. Bussolino
19	A transient kinetic study between signaling proteins: the case of the MEK–ERK interaction	2011	Nadia Barbero; Lucia Napione; Sonja Visentin; Maria Alvaro; Andrea Veglio; Federico Bussolino; Guido Viscardi
20	Tie-2-dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1.	2003	CASCONE I; AUDERO E; E. GIRAUDO; NAPIONE L; MANIERO F; PHILIPS MR; COLLARD JG; SERINI G; BUSSOLINO F